Innoviva (INVA) Financials: Revenue & Earnings
$1.52B
Market Cap
4.29
P/E
8.69
Forward P/E
70
Score
INVA price $21.04 +0.10 +0.48%
Stocklytics score rationale: value 72, quality 71, growth 67.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 133569000 | 217217000 | 261004000 | 261016000 | 336794000 | 391866000 | 331339000 | 310463000 | 358711000 | 425128000 |
Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs…
INVA fair value $29.79. Price $21.04. Price is 29% below fair value.
Below fair value, but more expensive than usual. A smaller discount than on 80% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 188.32M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 72.25M. Net debt -281.92M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | 0.52 | — | 115.31M |
| 2026-08-05 | 1.14 | 0.44 | 119.59M | 110.98M |
| 2026-05-06 | 0.44 | 0.43 | 97.99M | 101.57M |
| 2026-02-25 | 1.94 | 0.34 | 114.61M | 102.62M |
| 2025-11-05 | 1.08 | 0.46 | 107.80M | 91.36M |
| 2025-08-06 | 0.77 | 0.57 | 100.28M | 92.04M |
| 2025-05-07 | 0.74 | 0.29 | 88.63M | 82.67M |
| 2025-02-26 | 0.26 | 0.34 | 91.81M | 86.80M |
| 2024-11-06 | 0.02 | 0.27 | 89.51M | 76.91M |
| 2024-07-31 | -0.55 | 0.24 | 99.90M | 74.69M |
| 2024-05-08 | 0.46 | 0.17 | 77.50M | 68.00M |
| 2024-03-01 | 0.76 | 0.23 | 85.84M | 75.52M |
| 2023-11-01 | 0.98 | 0.27 | 67.26M | 75.66M |
| 2023-08-02 | 0.02 | 0.26 | 80.99M | 67.92M |
| 2023-04-26 | 0.42 | 0.23 | 76.37M | 62.01M |
| 2023-02-28 | 0.25 | 0.41 | 65.80M | 58.85M |
| 2022-11-09 | 2.80 | 2.75 | 67.26M | 62.60M |
| 2022-07-27 | 0.05 | 1.47 | 108.22M | 214.78M |
| 2022-04-27 | 0.35 | 0.44 | 90.06M | 86.40M |
| 2022-02-09 | 0.55 | 0.41 | 107.68M | 106.37M |
| 2021-10-27 | 0.90 | 0.43 | 97.86M | 76.04M |
| 2021-07-28 | 0.90 | 0.29 | 100.81M | 111.23M |
| 2021-04-28 | 0.84 | -0.01 | 85.52M | — |
| 2021-02-03 | 0.48 | 0.40 | 90.48M | 74.50M |
| 2020-10-28 | 0.28 | 0.42 | 88.69M | 143.27M |
| 2020-07-29 | 0.69 | 0.32 | 78.95M | 68.69M |
| 2020-04-29 | 0.59 | 0.36 | 78.68M | 70.32M |
| 2020-02-05 | 0.42 | 0.50 | 75.97M | 90.44M |
| 2019-10-30 | 0.36 | 0.37 | 65.75M | 67.58M |
| 2019-07-24 | 0.34 | 0.43 | 64.11M | 81.08M |
| 2019-05-01 | 0.31 | 0.36 | 55.18M | 64.08M |
| 2019-02-06 | 2.34 | 0.65 | 79.86M | 86.51M |
| 2018-10-31 | 0.43 | 0.49 | 61.68M | 70.31M |
| 2018-07-26 | 0.49 | 0.55 | 67.09M | 75.32M |
| 2018-04-26 | 0.27 | 0.53 | 52.38M | 102.86M |
| 2018-02-08 | 0.50 | 0.42 | 69.52M | 58.38M |
| 2017-10-25 | 0.22 | 0.31 | 48.64M | 68.48M |
| 2017-07-26 | 0.30 | 0.27 | 58.56M | 52.74M |
| 2017-04-27 | 0.18 | 0.27 | 40.49M | 72.90M |
| 2017-02-09 | 0.22 | 0.19 | 43.61M | 37.65M |
Yield 0.00%. Payout ratio 0.00%. Frequency Quarterly.
Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2015-09-08 | $0.25 | 2015-09-10 | 2015-09-30 | Quarterly |
| 2015-06-10 | $0.25 | 2015-06-12 | 2015-06-30 | Quarterly |
| 2015-03-10 | $0.25 | 2015-03-12 | 2015-03-31 | Quarterly |
| 2014-11-21 | $0.25 | 2014-11-25 | 2014-12-23 | Quarterly |
| 2014-08-26 | $0.25 | 2014-08-28 | 2014-09-18 | Quarterly |
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-20 | Zhen Marianne | Sell | 1.13K | $21.00 | 23.67K |
| 2026-08-20 | Basso Stephen | Sell | 558 | $21.00 | 11.72K |
| 2026-08-20 | Raifeld Pavel | Sell | 1.13K | $21.00 | 23.73K |
| 2026-05-20 | Basso Stephen | Sell | 559 | $22.24 | 12.43K |
| 2026-05-20 | Raifeld Pavel | Sell | 1.13K | $22.24 | 25.13K |
| 2026-05-20 | Zhen Marianne | Sell | 1.13K | $22.24 | 25.06K |
| 2026-05-18 | Linden Josephine | Buy | 9.46K | — | — |
| 2026-05-18 | Linden Josephine | Buy | 9.17K | $21.80 | 199.82K |
| 2026-05-18 | Linden Josephine | Buy | 5.73K | — | — |
| 2026-05-18 | Linden Josephine | Other | 0 | — | — |
| 2026-05-15 | Basso Stephen | Buy | 1.12K | — | — |
| 2026-05-15 | Raifeld Pavel | Buy | 1.12K | — | — |
| 2026-05-04 | Raifeld Pavel | Buy | 312.50K | $22.99 | 7.18M |
| 2026-05-04 | Raifeld Pavel | Buy | 126.65K | — | — |
| 2026-05-04 | DiPaolo Mark | Buy | 9.79K | — | — |
| 2026-05-04 | DiPaolo Mark | Buy | 10.00K | $22.99 | 229.90K |
| 2026-05-04 | Zhen Marianne | Buy | 12.77K | — | — |
| 2026-05-04 | Zhen Marianne | Buy | 31.50K | $22.99 | 724.18K |
| 2026-05-04 | Schlesinger Sarah J. | Buy | 9.79K | — | — |
| 2026-05-04 | Schlesinger Sarah J. | Buy | 10.00K | $22.99 | 229.90K |
| 2026-05-04 | Basso Stephen | Buy | 93.75K | $22.99 | 2.16M |
| 2026-05-04 | Basso Stephen | Buy | 37.99K | — | — |
| 2026-05-04 | Small Derek A | Buy | 9.79K | — | — |
| 2026-05-04 | Small Derek A | Buy | 10.00K | $22.99 | 229.90K |
| 2026-05-04 | Haimovitz Jules | Buy | 9.79K | — | — |
| 2026-05-04 | Haimovitz Jules | Buy | 10.00K | $22.99 | 229.90K |
| 2026-02-20 | Basso Stephen | Sell | 1.24K | $23.39 | 29.10K |
| 2026-02-20 | Raifeld Pavel | Sell | 2.99K | $23.39 | 69.84K |
| 2026-02-20 | Zhen Marianne | Sell | 2.46K | $23.39 | 57.54K |
| 2025-11-20 | Basso Stephen | Sell | 237 | $21.16 | 5.01K |
| 2025-11-20 | Zhen Marianne | Sell | 992 | $21.16 | 20.99K |
| 2025-11-15 | Basso Stephen | Buy | 604 | — | — |
| 2025-11-03 | Basso Stephen | Buy | 27.61K | $18.11 | 500.00K |
| 2025-11-03 | Raifeld Pavel | Buy | 110.44K | $18.11 | 2.00M |
| 2025-08-20 | Basso Stephen | Sell | 237 | $19.95 | 4.73K |
| 2025-08-20 | Zhen Marianne | Sell | 991 | $19.95 | 19.77K |
| 2025-05-20 | Zhen Marianne | Sell | 992 | $18.78 | 18.63K |
| 2025-05-20 | Basso Stephen | Sell | 237 | $18.78 | 4.45K |
| 2025-05-19 | Small Derek A | Buy | 12.08K | — | — |
| 2025-05-19 | Small Derek A | Buy | 10.00K | $18.63 | 186.30K |
| 2025-05-19 | DiPaolo Mark | Buy | 12.08K | — | — |
| 2025-05-19 | DiPaolo Mark | Buy | 10.00K | $18.63 | 186.30K |
| 2025-05-19 | Schlesinger Sarah J. | Buy | 12.08K | — | — |
| 2025-05-19 | Schlesinger Sarah J. | Buy | 10.00K | $18.63 | 186.30K |
| 2025-05-19 | Haimovitz Jules | Buy | 12.08K | — | — |
| 2025-05-19 | Haimovitz Jules | Buy | 10.00K | $18.63 | 186.30K |
| 2025-05-15 | Raifeld Pavel | Buy | 1.86K | — | — |
| 2025-05-15 | Basso Stephen | Buy | 1.35K | — | — |
| 2025-03-14 | Raifeld Pavel | Buy | 243.75K | $17.39 | 4.24M |
| 2025-03-14 | Raifeld Pavel | Buy | 37.38K | $17.39 | 649.99K |
| 2025-03-06 | DENNER ALEXANDER J | Sell | 1.20M | $17.52 | 20.96M |
| 2025-03-05 | DENNER ALEXANDER J | Sell | 270.37K | $17.63 | 4.77M |
| 2025-03-04 | DENNER ALEXANDER J | Other | 0 | — | — |
| 2025-03-04 | DENNER ALEXANDER J | Sell | 151.18K | $17.63 | 2.67M |
| 2025-02-24 | Zhen Marianne | Buy | 30.30K | $18.08 | 547.82K |
| 2025-02-24 | Zhen Marianne | Buy | 8.94K | $18.08 | 161.60K |
| 2025-02-24 | Basso Stephen | Buy | 100.83K | $18.08 | 1.82M |
| 2025-02-24 | Basso Stephen | Buy | 10.57K | $18.08 | 191.09K |
| 2025-02-20 | Zhen Marianne | Sell | 2.56K | $18.07 | 46.35K |
| 2025-02-20 | Basso Stephen | Sell | 1.11K | $18.07 | 19.99K |
| 2024-11-20 | Zhen Marianne | Sell | 976 | $19.15 | 18.69K |
| 2024-11-15 | Basso Stephen | Buy | 843 | — | — |
| 2024-11-15 | Zhen Marianne | Buy | 300 | — | — |
| 2024-08-20 | Zhen Marianne | Sell | 975 | $18.49 | 18.03K |
| 2024-06-17 | Srivastava Sapna | Buy | 13.92K | — | — |
| 2024-06-17 | Srivastava Sapna | Buy | 10.00K | $16.16 | 161.60K |
| 2024-06-17 | Small Derek A | Buy | 13.92K | — | — |
| 2024-06-17 | Small Derek A | Buy | 10.00K | $16.16 | 161.60K |
| 2024-06-17 | Schlesinger Sarah J. | Buy | 13.92K | — | — |
| 2024-06-17 | Schlesinger Sarah J. | Buy | 10.00K | $16.16 | 161.60K |
| 2024-06-17 | Odysseas Kostas D | Buy | 13.92K | — | — |
| 2024-06-17 | Odysseas Kostas D | Buy | 10.00K | $16.16 | 161.60K |
| 2024-06-17 | Haimovitz Jules | Buy | 13.92K | — | — |
| 2024-06-17 | Haimovitz Jules | Buy | 10.00K | $16.16 | 161.60K |
| 2024-06-17 | DiPaolo Mark | Buy | 13.92K | — | — |
| 2024-06-17 | DiPaolo Mark | Buy | 10.00K | $16.16 | 161.60K |
| 2024-05-20 | Ronsheim Matthew | Sell | 268 | $16.13 | 4.32K |
| 2024-05-20 | Zhen Marianne | Sell | 976 | $16.13 | 15.74K |
| 2024-04-29 | Small Derek A | Sell | 833 | — | — |
| 2024-04-29 | Small Derek A | Sell | 1.21K | — | — |
| 2024-03-05 | Basso Stephen | Buy | 25.90K | $14.88 | 385.38K |
| 2024-03-05 | Basso Stephen | Buy | 12.10K | $14.88 | 179.99K |
| 2024-03-05 | Ronsheim Matthew | Buy | 27.34K | $14.88 | 406.79K |
| 2024-03-05 | Ronsheim Matthew | Buy | 12.77K | $14.88 | 189.99K |
| 2024-03-05 | Zhen Marianne | Buy | 23.02K | $14.88 | 342.57K |
| 2024-03-05 | Zhen Marianne | Buy | 10.75K | $14.88 | 159.99K |
| 2024-03-05 | Raifeld Pavel | Buy | 150.00K | $20.00 | 3.00M |
| 2024-03-05 | Raifeld Pavel | Buy | 100.00K | $18.00 | 1.80M |
| 2024-03-05 | Raifeld Pavel | Buy | 75.00K | $14.88 | 1.12M |
| 2024-02-20 | Ronsheim Matthew | Sell | 807 | $15.80 | 12.75K |
| 2024-02-20 | Zhen Marianne | Sell | 2.86K | $15.80 | 45.22K |
| 2024-01-18 | Ronsheim Matthew | Buy | 60.00K | $16.05 | 963.00K |
| 2024-01-18 | Ronsheim Matthew | Sell | 1.60K | $16.05 | 25.68K |
| 2024-01-01 | Ronsheim Matthew | Sell | 0 | — | — |
| 2024-01-01 | Ronsheim Matthew | Sell | 17.47K | — | — |
| 2024-01-01 | Ronsheim Matthew | Sell | 16.50K | $12.98 | 214.17K |
| 2024-01-01 | Ronsheim Matthew | Sell | 16.60K | $12.48 | 207.17K |
| 2023-11-20 | Zhen Marianne | Sell | 784 | $13.62 | 10.68K |
| 2023-11-15 | Zhen Marianne | Buy | 302 | — | — |
| 2023-11-15 | Zhen Marianne | Sell | 5.59K | $14.01 | 78.30K |
Latest filed quarter: Q2 2026.
Institutions holding: 310, holders +23 vs prior quarter. Ownership 102.18%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 11.56M | 247.36K | +2.19% | 262.42M |
| DIMENSIONAL FUND ADVISORS LP | 4.49M | 57.63K | +1.30% | 102.06M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.22M | -4.68K | -0.11% | 95.84M |
| RENAISSANCE TECHNOLOGIES LLC | 4.04M | -19.10K | -0.47% | 91.67M |
| STATE STREET CORP | 3.27M | 207.63K | +6.78% | 74.22M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.16M | 16.47K | +0.52% | 71.72M |
| MILLENNIUM MANAGEMENT LLC | 2.54M | 261.66K | +11.48% | 57.71M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.07M | 144.99K | +7.51% | 47.13M |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 2.02M | -517 | -0.03% | 45.96M |
| BOSTON PARTNERS | 1.93M | 209.09K | +12.16% | 43.78M |
| SARISSA CAPITAL MANAGEMENT LP | 1.89M | -240.35K | -11.28% | 42.94M |
| BANK OF AMERICA CORP /DE/ | 1.67M | 47.70K | +2.94% | 37.87M |
| GOLDMAN SACHS GROUP INC | 1.62M | 26.71K | +1.68% | 36.79M |
| AMERICAN CENTURY COMPANIES INC | 1.50M | -411.98K | -21.57% | 34.02M |
| MARSHALL WACE, LLP | 1.45M | -50.09K | -3.33% | 33.03M |
| MORGAN STANLEY | 1.22M | -89.92K | -6.86% | 27.73M |
| ROYCE & ASSOCIATES LP | 1.17M | 111.24K | +10.48% | 26.63M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.15M | -12.41K | -1.07% | 26.15M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 1.15M | 1.15M | New | 26.15M |
| TWO SIGMA INVESTMENTS, LP | 1.03M | -451.46K | -30.42% | 23.46M |
| QUBE RESEARCH & TECHNOLOGIES LTD | 974.12K | 188.02K | +23.92% | 22.12M |
| DEUTSCHE BANK AG\ | 917.96K | 9.89K | +1.09% | 20.85M |
| NORTHERN TRUST CORP | 831.20K | 56.90K | +7.35% | 18.88M |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 830.37K | -61.96K | -6.94% | 18.86M |
| INVESCO LTD. | 732.72K | -171.56K | -18.97% | 16.64M |
Innoviva, Inc. (INVA) trades at $21.04, with a market cap of $1.52B and a trailing P/E of 4.29. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 133569000 | 217217000 | 261004000 | 261016000 | 336794000 | 391866000 | 331339000 | 310463000 | 358711000 | 425128000 |
Insights · Dividends · Forecast · Financials · Learn
$1.52B
Market Cap
4.29
P/E
8.69
Forward P/E
70
Score